S O'Brien1. Show Affiliations » 1. Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA.
Abstract
Entities: Disease
Mesh: See more » Antineoplastic Combined Chemotherapy Protocols/therapeutic useCyclophosphamide/administration & dosageDoxorubicin/administration & dosageGranulocyte Colony-Stimulating Factor/therapeutic useHumansLeukemia, Lymphocytic, Chronic, B-Cell/drug therapyLeukemia, Lymphocytic, Chronic, B-Cell/therapyMitoxantrone/administration & dosageSplenectomyVidarabine/administration & dosageVidarabine/analogs & derivatives
Substances: See more » Granulocyte Colony-Stimulating FactorDoxorubicinCyclophosphamideMitoxantroneVidarabinefludarabine
Year: 1998 PMID: 9685176
Source DB: PubMed Journal: Semin Hematol ISSN: 0037-1963 Impact factor: 3.851